On October 21, 2022, MedX Health Corp closed the transaction. The company issued 20 convertible loan notes at an issue price of CAD 50,000 per note for gross proceeds of CAD 1,100,000 in the transaction. In accordance with relevant regulatory and stock exchange policies, the securities issued are restricted from trading for a period of four months from the original issue dates.

On the same date, the company issued 2 convertible loan notes at an issue price of CAD 50,000 per note for gross proceeds of CAD 100,000 in its second and final tranche closing.